Interestingly, a subset of AMLs overexpressing FLT3, in the absence of mutations of this receptor, overexpress also CD123 and may represent a peculiar AML subset, whose proliferation was driven by the overexpressed CD123 and FLT3 [55]. The gene discussed is FLT3; the disease is acute myeloid leukemia.